Navigation Links
New technology enhances therapeutic potential of cord blood stem cells
Date:6/6/2008

A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research from Rush University Medical Center being presented at the 6th Annual International Umbilical Cord Blood Transplantation Symposium, June 6-7 in Los Angeles.

Kent W. Christopherson II, PhD, assistant professor of medicine and researcher in the Sections of Hematology and Stem Cell Transplantation at Rush, is researching a CD26 Inhibitor, a small molecule enzyme inhibitor that enhances directional homing of stem cells to the bone marrow by increasing the responsiveness of donor stem cells to a natural homing signal. Homing is the process by which the donor stem cells find their way to the bone marrow. It is the first and essential step in stem cell transplantation.

Cord blood is increasingly being used by transplant centers as an alternative source of stem cells for the treatment of blood cancers, including myeloma, lymphoma and leukemia. The cells, which are collected from the umbilical cord after the baby is delivered and separated from the cord, are most commonly used for bone marrow transplantation when a donor from a patient's family or an unrelated donor does not produce an appropriate bone marrow match.

The current drawback to the usage of cord blood cells is that due to the limited volume and cell number, there are generally only enough cells available from a single cord blood collection for children or very small adults. Cord blood cells also usually take longer to engraft, leaving the patient at a high risk for infection longer than donor matched transplanted marrow or peripheral blood stem cells. The goal of Christopherson's research is to increase the transplant efficiency of umbilical cord blood and ultimately make transplant safer and available to all patients who require this treatment.

In his discussion on "Strategies to Improve Homi
'/>"/>

Contact: Kim Waterman
Kimberly_Waterman@rush.edu
312-942-7820
Rush University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology
2. Synergy between biology and physics drives cell-imaging technology
3. Brown to host conference on advances in neurotechnology
4. DHS, business leaders discuss technology to protect US at Homeland Security conference
5. Scripps Research Institute awarded patent for remarkable chemical technology
6. Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems
7. IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization
8. Atmel Receives Frost & Sullivans Technology Innovation Award for FingerChip(R) Biometric Sensor
9. Too much technology may be killing beneficial bacteria
10. Scientists make chemical cousin of DNA for use as new nanotechnology building block
11. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., SUNNYVALE, Calif., Dec. 1 Gestur...Release 3.0 - a turnkey, portable, plug and play i...ng, exhibits, entertainment and touring promotions...of patents in camera-enabled gesture recognition t...d entertainment systems. ,, Guaranteed for qual...
(Date:12/1/2009)...io Ohio State University cancer researchers have ... brain-tumor cells and blocks the growth of new tu...iruses designed to kill cancer cells oncolytic vi...brain tumors if they also carry a gene for a prote...in, called vasculostatin, is normally produced in ...
(Date:12/1/2009)...scientists, one from the United States, the other ...he leader of his wolf pack, on remote Ellesmere Is...al to finally find out what these "North Pole wol... the harshest areas of the world., "We first enc...id Mech, a renowned U.S. Geological Survey (USGS) ...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Tumor-attacking virus strikes with 'one-two punch' 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 1CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 2CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 3CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World 13833 4Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 1Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 2Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 3Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 56134 485 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 185 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 285 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 385 25 of Single Men Would Date Heavy Women 3B 90 25 of Single Women Feel Men Cant See Past a Few Extra Pounds States Date com 56130 4
... A recently discovered facet of the breast cancer ...ing mutation of BRCA1 to formation of large blood ...findings demonstrate that, in addition to an impai...tiation, mutation of BRCA1 is also linked to manip...h appears in the July issue of Cancer Cell, publis...
... Acting as a genetic Trojan horse, an experimental... its way into prostate cancer cells and then sprin...al cells unarmed. , The drug, developed at Duke U... material, called targeting RNA, to enter cancer c...top the expression of a protein that keeps the cel...
... Titanium dental implants coated with proteins tha...n treating tooth loss due to gum disease, research...pplied a protein onto implants that directs endoge...result was a nearly complete regeneration of lost ...dontics in MCG,s School of Dentistry. , Loss of ...
Other Biology News:Study identifies new role for breast cancer susceptibility gene 2Experimental RNA-based drug kills prostate cancer cells effectively and safely 2Protein-coated dental implants could improve bone regeneration 2
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - O...ny") (TSX:ONC; NASDAQ: ONCY ) announced today that...offering, the underwriters have exercised in full ...ional 637,500 units. Each unit is comprised of one...arrant, and was sold at a price of US$3.00 per uni...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte...el oral JAK2 inhibitor, SB1518, at The American So...tion in New Orleans. ,, Data will be presented ...lation trial of SB1518 detailing its safety, toler...) profile in dose levels ranging from 100 to 600 m...
(Date:12/2/2009)... The Scientist, a leading scientific...metrics’ Evolve “Intelligent” EM...dquo;Top 10 Innovations of 2009. , ...™ EMCCD camera from Photometrics ®, a ...and EMCCD cameras for the life sciences, was ranke...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlink... is available in its catalogue: ,, Industrial ...w.reportlinker.com/p0164431/Industrial-Enzymes---A...es market is an oligopoly with few strong players ...ket activities. Keen competition and commoditizati...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...Madison, Wis. - Wisconsin Gov. Jim Doyle , notin... passage of bipartisan legislation to overturn Pr...ic stem cell research, said Congressional inaction...le noted that Senate Majority Leader Bill Frist ,...tment to schedule a vote on the Stem Cell Research...
...Waukesha, Wis. - An imaging technology that holds...ive cardiac care will get its first commercial tes...e , which holds 25 patents related to hybrid imagi...n of the company,s new Discovery VCT at Brigham a...hnology is able to capture images of the heart and...
... While the lunar calendar may not agree, Memorial ... morning, millions of Americans have brushed off t...e knowledge that school will soon adjourn for the ...t three months will pose plenty of opportunity to ... the summer slide, when late nights in the office ...
Other Biology Technology:GE announces first installation of Discovery VCT 2Summer marks countdown to DEMOfall 2Summer marks countdown to DEMOfall 3
Cryopreservation Service from AbD Serotec
... mutS and ES1301 mutS are mismatch repair minus st...pair of the newly synthesized unmethylated strand ...ing them helpful in such systems as the GeneEditor...1301 and BMH 71-18 mutS are recA+, therefore inser...
Polaroid B&W positive, 3 x 4 inch pack film, 20 exp from Hoefer, Inc.
Rat IFN-gamma ELISpot Development Kit from R&D Systems
Biology Products: